Therapeutic proteins : (Record no. 63204)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05142cam a2200793Ii 4500 |
| 001 - CONTROL NUMBER | |
| control field | sulb-eb0031552 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | BD-SySUS |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20170713221303.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120309t20122012gw a ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DG1 |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | DG1 |
| Modifying agency | N$T |
| -- | E7B |
| -- | YDXCP |
| -- | OCLCQ |
| -- | OCLCF |
| -- | MMU |
| -- | OCLCQ |
| -- | OCLCO |
| -- | NLGGC |
| -- | IDEBK |
| -- | COO |
| -- | OCLCQ |
| -- | DEBBG |
| -- | EBLCP |
| -- | BD-SySUS |
| 019 ## - | |
| -- | 778622647 |
| -- | 781540190 |
| -- | 785779913 |
| -- | 817058699 |
| -- | 824108355 |
| -- | 961501435 |
| -- | 962591607 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527644827 |
| Qualifying information | (oBook) |
| International Standard Book Number | 3527644822 |
| Qualifying information | (oBook) |
| International Standard Book Number | 9783527644797 |
| Qualifying information | (ePDF) |
| International Standard Book Number | 3527644792 |
| Qualifying information | (ePDF) |
| International Standard Book Number | 9783527644780 |
| Qualifying information | (ePub) |
| International Standard Book Number | 3527644784 |
| Qualifying information | (ePub) |
| International Standard Book Number | 9783527644803 |
| Qualifying information | (Mobi) |
| International Standard Book Number | 3527644806 |
| Qualifying information | (Mobi) |
| International Standard Book Number | 128345422X |
| International Standard Book Number | 9781283454223 |
| Canceled/invalid ISBN | 9783527328499 |
| Qualifying information | (print ; |
| -- | alk. paper) |
| Canceled/invalid ISBN | 3527328491 |
| Qualifying information | (print ; |
| -- | alk. paper) |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000049014070 |
| OCLC library identifier | DKDLA |
| System control number | 820120-katalog:000601021 |
| OCLC library identifier | NZ1 |
| System control number | 14694101 |
| OCLC library identifier | NZ1 |
| System control number | 15916291 |
| OCLC library identifier | DEBBG |
| System control number | BV043394342 |
| OCLC library identifier | AU@ |
| System control number | 000059228061 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)779616898 |
| Canceled/invalid control number | (OCoLC)778622647 |
| -- | (OCoLC)781540190 |
| -- | (OCoLC)785779913 |
| -- | (OCoLC)817058699 |
| -- | (OCoLC)824108355 |
| -- | (OCoLC)961501435 |
| -- | (OCoLC)962591607 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 10.1002/9783527644827 |
| Source of stock number/acquisition | Wiley InterScience |
| Note | http://www3.interscience.wiley.com |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS431.P75 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QU 55 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.3 |
| Edition number | 23 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 245 00 - TITLE STATEMENT | |
| Title | Therapeutic proteins : |
| Remainder of title | strategies to modulate their plasma half-lives / |
| Statement of responsibility, etc. | edited by Roland Kontermann. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Weinheim, Germany : |
| Name of producer, publisher, distributor, manufacturer | Wiley-Blackwell, an imprint of John Wiley & Sons, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2012. |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (374 pages) : |
| Other physical details | illustrations (some color) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | General information -- Half-life modulating strategies : an introduction -- Pharmacokinetics and half-life of protein therapeutics -- Half-life extension through chemical and post-translational modifications -- Half-life extension through PEGylation -- Half-life extension of therapeutic proteins via genetic fusion to recombinant PEG mimetics -- Half-life extension through O-glycosylation -- Polysialic acid and polysialylation to modulate antibody pharmacokinetics -- Half-life extension through HESylation -- Half-life modulation involving recycling by the neonatal Fc receptor -- The biology of the neonatal Fc receptor (FcRn) -- half-life extension by fusion to the Fc region -- Monomeric Fc fusion technology: an approach to create long-lasting clotting factors -- The diverse roles of FcRn: implications for antibody engineering -- Half-life extension by fusion to recombinant albumin -- AlbudAb technology platform: versatile albumin binding domains for the development of therapeutics with tunable half-lives -- Half-life extension by binding to albumin through an albumin binding domain -- Half-life extension by binding to albumin through small molecules -- Half-life extension with pharmaceutical formulations -- Half-life extension with pharmaceutical formulations: liposomes -- Half-life extension with pharmaceutical formulations: nanoparticles by the miniemulsion process. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Online resource; title from resource home page (ebrary, viewed on June 17, 2014). |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Protein drugs |
| General subdivision | Design. |
| Topical term or geographic name as entry element | Proteins |
| General subdivision | Therapeutic use. |
| Topical term or geographic name as entry element | Proteins |
| General subdivision | pharmacokinetics. |
| Topical term or geographic name as entry element | Half-Life. |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| Topical term or geographic name as entry element | Protein drugs |
| General subdivision | Design. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst01079680 |
| Topical term or geographic name as entry element | Proteins |
| General subdivision | Therapeutic use. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst01079767 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kontermann, Roland, |
| Dates associated with a name | 1961- |
| Relator term | editor. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Title | Therapeutic proteins. |
| Place, publisher, and date of publication | Weinheim, Germany : Wiley-VCH, ©2011 |
| International Standard Book Number | 9783527328499 |
| Record control number | (DLC) 2012540834 |
| -- | (OCoLC)768072878 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527644827">http://onlinelibrary.wiley.com/book/10.1002/9783527644827</a> |
| Public note | Wiley Online Library [Free Download only for SUST IP] |
| 938 ## - | |
| -- | EBL - Ebook Library |
| -- | EBLB |
| -- | EBL4044288 |
| -- | ebrary |
| -- | EBRY |
| -- | ebr10531468 |
| -- | EBSCOhost |
| -- | EBSC |
| -- | 433551 |
| -- | Ingram Digital eBook Collection |
| -- | IDEB |
| -- | 345422 |
| -- | YBP Library Services |
| -- | YANK |
| -- | 7484192 |
| -- | YBP Library Services |
| -- | YANK |
| -- | 7425161 |
| -- | YBP Library Services |
| -- | YANK |
| -- | 12679413 |
| 994 ## - | |
| -- | 92 |
| -- | DG1 |
No items available.